Can a tailored drug strategy heal Crohn's gut damage?
NCT ID NCT07600255
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether the drug ustekinumab can help people with moderate to severe Crohn's disease reach 'deep remission' — meaning no symptoms, healed gut lining, and healed gut wall. Researchers followed 156 patients for 44 weeks and checked what factors helped predict this deep healing. The goal is to better personalize treatment for each patient.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Second Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, 325000, China